IIT RESEARCH INSTITUTE - IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS
Key Details
Description
IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS
Context & Analysis
On Sep 6, 2017, Department of Health and Human Services obligated $626,265.68 to IIT RESEARCH INSTITUTE for igf::ot::igf next preclinical toxicology&pharmacology of drugs developed for cancer patients, to#3, exploratory studies of ccr4 cart cells. The award is classified under NAICS 541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES. Performance is located in CHICAGO, IL. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541690 — related awards are listed below.
Contractor Information
Similar Awards
IGF::OT::IGF SAMHSA'S PERFORMANCE ACCOUNTABILITY AND REPORTING SYSTEM (SPARS)
RESEARCH TRIANGLE INSTITUTE
$41.8M
HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) CLIN 0002 BASE AWARD
NATIONAL OPINION RESEARCH CENTER
$33.7M
HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) CLIN 0002 BASE AWARD
NATIONAL OPINION RESEARCH CENTER
$33.7M
SENTINEL 2.0 BRIDGE CONTRACT
HARVARD PILGRIM HEALTH CARE, INC.
$32.9M
MIDS DEVELOPMENT, REEVALUATION AND IMPLEMENTATION OF OUTCOME/EFFICIENCY MEASURES FOR HOSPITAL AND ELIGIBLE CLINICIANS
YALE NEW HAVEN HEALTH SERVICES CORPORATION
$31.1M
Stay Updated
Get notified about new opportunities matching your interests.